Caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia. Issue 8 (9th June 2022) - Gambacorti‐Passerini, Carlo; Nicolini, Franck Emmanuel; Larson, Richard A.; Aroldi, Andrea; Fontana, Diletta; Piazza, Rocco; le Coutre, Philipp; Antolini, Laura; Assouline, Sarit